Search Results

A Malignant FLAME.

• Authors : Stix, Gary; G. S.

• Source: Scientific American. Jul2007, Vol. 297 Issue 1, p60-67. 8p.

Record details

Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry.

• Authors : Lacan, Claire; Lambert, Jérôme; Forcade, Edouard

Subjects: Anti-thymoglobulin; Bone marrow; Graft source

• Source: Journal of Hematology and Oncology, 17, 2 (2024)

Record details

Mise à jour du calendrier vaccinal après allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC).

• Authors : Conrad, Anne; Beguin, Yves; Guenounou, Sarah

Subjects: Allogeneic haematopoietic stem cell transplantation; Allogreffe de cellules souches hématopoïétiques; Vaccination

• Source: Bulletin du Cancer, 111 (25), S40-S49 (2024)

Record details

Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study.

• Authors : Nakamura, Yoshiaki; Mizuno, Nobumasa; Sunakawa, Yu

Subjects: Trastuzumab; ERBB2 protein, human; tucatinib

• Source: Journal of Clinical Oncology, 41 (36), 5569 - 5578 (2023-12-20)

Record details

Neoadjuvant nivolumab + palbociclib + anastrozole for oestrogen receptor-positive/human epidermal growth factor receptor 2-negative primary breast cancer: Results from CheckMate 7A8.

• Authors : Jerusalem, Guy; Prat, Aleix; Salgado, Roberto

Subjects: Anastrozole; Aromatase inhibitors; Breast neoplasms

• Source: Breast, 72, 103580 (2023-12)

Record details

Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer.

• Authors : Alečković, Maša; Li, Zheqi; Zhou, Ningxuan

Subjects: B7-H1 Antigen; Immune Checkpoint Inhibitors; Nuclear Proteins

• Source: Molecular Cancer Therapeutics, 22 (11), 1304 - 1318 (2023-11-01)

Record details

Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2- advanced breast cancer receiving first-line ribociclib plus fulvestrant.

• Authors : Neven, P; Fasching, P A; Chia, S

Subjects: Advanced breast cancer; CDK4/6 inhibitor; First line

• Source: Breast Cancer Research, 25 (1), 103 (2023-08-31)

Record details

Transcriptome analysis reveals tumor microenvironment changes in glioblastoma.

• Authors : Hoogstrate, Youri; Draaisma, Kaspar; Ghisai, Santoesha A

Subjects: RNA-seq; extracellular matrix; glioblastoma

• Source: Cancer Cell, 41 (4), 678 - 692.e7 (2023-04-10)

Record details

Methylglyoxal: a novel upstream regulator of DNA methylation.

• Authors : Dube, Gaurav; Tiamiou, Assia; Bizet, Martin

Subjects: Breast cancer; DNA methylation; Metastasis

• Source: Journal of Experimental and Clinical Cancer Research, 42 (1), 78 (2023-03-31)

Record details

Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial.

• Authors : de Azambuja, E; Agostinetto, E; Procter, M

Subjects: HER2-positive; adjuvant; breast cancer

• Source: ESMO Open, 8 (1), 100772 (2023-02)

Record details